Open AccessResponse rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma
Author(s) -
Patrick Daniele,
Carla Mamolo,
Joseph C. Cappelleri,
Timothy J. Bell,
Alexander Neuhof,
Gabriel Tremblay,
Mihaela Musat,
A. Forsythe
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0267979
Subject(s) - medicine , clinical endpoint , multiple myeloma , progression free survival , surrogate endpoint , confidence interval , oncology , randomized controlled trial , meta analysis , minimal residual disease , overall survival , leukemia